In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Elacestrant, while exerting its therapeutic effects, can also cause some side ef···【more】
Release date:2026-03-16Recommended:93
Regarding the dosage of elacestrant, in addition to the recommended dose, approp···【more】
Release date:2026-03-16Recommended:97
Elacestrant is an estrogen receptor antagonist developed by the Italian company ···【more】
Release date:2026-03-16Recommended:97
Capmatinib is a targeted therapy for non-small cell lung cancer with MET exon 14···【more】
Release date:2026-03-13Recommended:103
Capmatinib (Tabrecta) is a highly selective MET receptor tyrosine kinase inhibit···【more】
Release date:2026-03-13Recommended:156
Ixazomib, as a novel targeted therapy, blocks the growth and proliferation of tu···【more】
Release date:2026-03-13Recommended:96
Ixazomib is an oral proteasome inhibitor primarily used clinically to treat mult···【more】
Release date:2026-03-13Recommended:127
Ibrutinib is an oral Bruton's tyrosine kinase (BTK) inhibitor that was first···【more】
Release date:2026-03-12Recommended:99
Ibrutinib (Imbruvica) is an oral Bruton's tyrosine kinase (BTK) inhibitor us···【more】
Release date:2026-03-12Recommended:85
Ibrutinib is a small molecule that acts as a potent, irreversible inhibitor of B···【more】
Release date:2026-03-12Recommended:94
Ibrutinib (Imbruvica) is a type of medication called a kinase inhibitor, used to···【more】
Release date:2026-03-12Recommended:83
What are the common adverse reactions to Gilteritinib fumarate?Common reactions ···【more】
Release date:2026-03-11Recommended:109